Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
An empirical study of publicly funded collaborative research projects in biotechnology identifies contractual provisions that govern the extent of access to and openness of research results.
Artificial intelligence-powered drug discovery is capturing breathless headlines, drug company deals, and investor capital, but the acceleration it promises will not happen overnight.
China is set to challenge the pre-eminence of the US drug market. If it can address gaps in its R&D ecosystem and clinical infrastructure, it may even become a home for biotech innovators.
With neuroinflammation, fibrosis, genomics and apoptosis research to the fore, Johns Hopkins is ramping up its output of startups with a little help from Korea.